Prelude Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,046
| Closed | -$22K | – | 1489 |
|
|
2020
Q3 | $22K | Sell |
1,046
-2,596
| -71% | -$54.6K | ﹤0.01% | 994 |
|
|
2020
Q2 | $86K | Buy |
+3,642
| New | +$86K | ﹤0.01% | 692 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1550 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 1694 |
|
|
2019
Q1 | – | Sell |
-2,948
| Closed | -$98K | – | 1712 |
|
|
2018
Q4 | $98K | Buy |
+2,948
| New | +$98K | 0.01% | 688 |
|
|
2018
Q3 | – | Sell |
-9,860
| Closed | -$590K | – | 1654 |
|
|
2018
Q2 | $590K | Buy |
9,860
+286
| +3% | +$17.1K | 0.04% | 371 |
|
|
2018
Q1 | $438K | Buy |
9,574
+800
| +9% | +$36.6K | 0.03% | 419 |
|
|
2017
Q4 | $350K | Buy |
8,774
+2,296
| +35% | +$91.6K | 0.03% | 445 |
|
|
2017
Q3 | $259K | Hold |
6,478
| – | – | 0.02% | 508 |
|
|
2017
Q2 | $279K | Sell |
6,478
-3,067
| -32% | -$132K | 0.03% | 425 |
|
|
2017
Q1 | $299K | Buy |
9,545
+2,488
| +35% | +$77.9K | 0.03% | 394 |
|
|
2016
Q4 | $178K | Sell |
7,057
-7,941
| -53% | -$200K | 0.02% | 588 |
|
|
2016
Q3 | $371K | Buy |
14,998
+2,917
| +24% | +$72.2K | 0.04% | 321 |
|
|
2016
Q2 | $246K | Sell |
12,081
-7,846
| -39% | -$160K | 0.03% | 400 |
|
|
2016
Q1 | $304K | Buy |
19,927
+9,327
| +88% | +$142K | 0.04% | 347 |
|
|
2015
Q4 | $142K | Buy |
10,600
+7,200
| +212% | +$96.5K | 0.02% | 636 |
|
|
2015
Q3 | $48K | Sell |
3,400
-300
| -8% | -$4.24K | 0.01% | 996 |
|
|
2015
Q2 | $63K | Sell |
3,700
-2,100
| -36% | -$35.8K | 0.01% | 992 |
|
|
2015
Q1 | $70K | Sell |
5,800
-14,300
| -71% | -$173K | 0.01% | 1114 |
|
|
2014
Q4 | $167K | Buy |
+20,100
| New | +$167K | 0.02% | 690 |
|